Based on 784 businesses audited.
Medical Devices, Pharma & Biotech Reputation: REVLIMID (Bristol Myers Squibb) (revlimid.com)
This is a high-substance, low-BS regulatory portal. It functions as a legal disclosure vehicle rather than a marketing site, prioritizing risk mitigation over persuasive fluff. The BS score is only raised by technical SEO deficiencies and the inherent repetitiveness of pharmaceutical CTAs.
Medical Devices, Pharma & Biotech Reputation: REVLIMID (Bristol Myers Squibb) (revlimid.com)
The website perfectly aligns with the Pharma and Biotech category. The content is dominated by regulatory-mandated safety disclosures, indications for use, and clinical risk assessments typical of a prescription medication portal.
“The score of 75 is driven primarily by the Identity and Authority pillar due to a lack of structured data and technical hierarchy issues. Information Density is exceptionally strong, keeping the score in the 'Low BS' range. The site is a benchmark for substance over signal, as mandated by pharmaceutical advertising laws.”